Search
for
Sort by
Research 301–330 of 1000+
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- New drugs: Agalsidase alfa
- Clinical Manifestations and Management of Acute Thallium Poisoning
- Late presentation of biotinidase deficiency with acute visual loss and gait disturbance
- Complications of Subcutaneous Contraception: A Review
- TRACE ELEMENTS IN MEDICINE
- Prevention and treatment of adverse effects related to chemotherapy for recurrent ovarian cancer
- Volatile organic compounds: A proinflammatory activator in autoimmune diseases
- Clinically-Relevant Chemotherapy Interactions with Complementary and Alternative Medicines in Patients with Cancer
- Clinical Case Notes. Lipoid proteinosis: a rare disorder with pathognomonic lid lesions
- Thallium
- Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
- Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat
- Effective Surgical Treatment of Cubital Tunnel Syndrome Based on Provocative Clinical Testing without Electrodiagnostics
- Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer
- Evaluation of ChatGPT Dermatology Responses to Common Patient Queries
- Clinical Case Notes. Malignant melanoma in eviscerated eyeball
- Clinical Case Notes. Retinoblastoma, microphthalmia and the chromosome 13q deletion syndrome
- Human urine-based therapeutics in Spain from the early 20th century to the present
- Ankle Range of Motion, Leg Pain, and Leg Edema Improvement in Patients With Venous Leg Ulcers
- Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC).
- Peter Kynaston Thomas, 28 June 1926–25 January 2008
- Clinical Snippets
- Wnt/β-Catenin Signaling in Diabetic Complications: Mechanisms and Therapeutic Potential
- Predictive value of the serum albumin change rate for therapeutic response to targeted therapy in patients with AIDS-related non-Hodgkin lymphoma
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Abstracts of the Final Year Projects of Pharm D Clinical Pharmacy Students Faculty of Pharmacy Beni-suef University Year 2024/2025
- Recent Therapy to Treat Various Types of Cancer: An Overview
- E-Poster
- LP-159 Studying the disease activity and the degree of internal organ damage in systemic lupus erythematosus patients in the Kazakh population